RNS Number : 5334W
McBride PLC
22 December 2021

22 December 2021


McBride plc


December 2021 - Bank Covenant Waiver


McBride plc (the "Group"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, today provides the following update to the markets.

Further to our announcement of 16 December 2021, we are pleased to announce that our banking group has waived the December 2021 covenant tests.

In reaching the agreement of the waiver, the Group has agreed to maintain liquidity (cash plus facility headroom) of at least £40 million. As referenced in the announcement on 16 December 2021, McBride continues to benefit from a strong liquidity position with c.£80 million in available additional funding. Furthermore, the Group has agreed not to pay dividends until it is in compliance with its existing covenants. The Group is working with its banking group to agree the June 2022 covenants ahead of McBride announcing its interim results for the 6 months ending 31 December 2021.

We are fully appreciative of the ongoing support that the banking group are giving to the Group through this period of uncertainty caused by the rapid and unprecedented rise in input costs and the ongoing macroeconomic supply chain challenges.


For further information, please contact:

McBride plc


Chris Smith, Chief Executive Officer

0161 203 7570

Mark Strickland, Chief Finance Officer

0161 203 7570


FTI Consulting LLP

020 3727 1017

Ed Bridges, Nick Hasell



This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.            

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.